Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses.

[1]  A. Massoud,et al.  Tregitopes improve murine asthma by promoting highly suppressive and antigen specific Tregs , 2020 .

[2]  A. D. De Groot,et al.  In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance , 2020, Human vaccines & immunotherapeutics.

[3]  M. J. Wood,et al.  Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis , 2019, Journal of Translational Medicine.

[4]  J. White,et al.  Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction , 2019, Scientific Reports.

[5]  H. Rammensee,et al.  The HLA Ligand Atlas. A resource of natural HLA ligands presented on benign tissues , 2019, bioRxiv.

[6]  A. D. De Groot,et al.  Highly conserved influenza T cell epitopes induce broadly protective immunity. , 2019, Vaccine.

[7]  W. van Eden,et al.  Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid Arthritis , 2019, Front. Immunol..

[8]  D. Glass,et al.  T regulatory cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells , 2018, Nature Immunology.

[9]  C. Hsieh,et al.  Central CD4+ T cell tolerance: deletion versus regulatory T cell differentiation , 2018, Nature Reviews Immunology.

[10]  N. Indrawattana,et al.  Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy , 2018, Scientific Reports.

[11]  J. Lieberman,et al.  Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation. , 2017, JCI insight.

[12]  T. Glant,et al.  An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis. , 2017, Vaccine.

[13]  Arnone Nithichanon,et al.  A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines , 2017, Scientific Reports.

[14]  Oliver Kohlbacher,et al.  HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy , 2017, Oncoimmunology.

[15]  A. Arce-Sillas,et al.  Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation , 2016, Journal of immunology research.

[16]  M. Linder,et al.  Mechanism of Copper Uptake from Blood Plasma Ceruloplasmin by Mammalian Cells , 2016, PloS one.

[17]  W. Toyofuku,et al.  Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy , 2015, PloS one.

[18]  D. Isenberg,et al.  Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study , 2015, Lupus Science & Medicine.

[19]  A. D. De Groot,et al.  H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance , 2015, Human vaccines & immunotherapeutics.

[20]  A. D. De Groot,et al.  Tregitope: Immunomodulation powerhouse. , 2014, Human immunology.

[21]  E. Shevach,et al.  tTregs, pTregs, and iTregs: similarities and differences , 2014, Immunological reviews.

[22]  D. Scott,et al.  Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  D. Bigner,et al.  Human Regulatory T Cells Kill Tumor Cells through Granzyme-Dependent Cytotoxicity upon Retargeting with a Bispecific Antibody , 2013, Cancer Immunology Research.

[24]  D. Scott,et al.  Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes , 2013, Journal of diabetes research.

[25]  D. Scott,et al.  In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity , 2012, Journal of Clinical Immunology.

[26]  Anne S De Groot,et al.  Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis. , 2012, World journal of gastroenterology.

[27]  D. Scott,et al.  Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis , 2011, Neurology research international.

[28]  Bjoern Peters,et al.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.

[29]  Eun Seong Lee,et al.  Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy. , 2010, Bioconjugate chemistry.

[30]  R. Camire,et al.  The molecular basis of factor V and VIII procofactor activation , 2009, Journal of thrombosis and haemostasis : JTH.

[31]  K. High,et al.  Suppression of CTL Responses against AAV-Capsid Epitopes by Peptide-Induced Regulatory T Cells. , 2009 .

[32]  C. Baecher-Allan,et al.  Cutting Edge: Responder T Cells Regulate Human DR+ Effector Regulatory T Cell Activity via Granzyme B1 , 2009, The Journal of Immunology.

[33]  A. Sharabi,et al.  The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models , 2009, Immunology.

[34]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[35]  Daniel J. Campbell,et al.  T-bet controls regulatory T cell homeostasis and function during type-1 inflammation , 2009, Nature Immunology.

[36]  D. Scott,et al.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". , 2008, Blood.

[37]  Loren Gragert,et al.  High-resolution HLA alleles and haplotypes in the United States population. , 2007, Human immunology.

[38]  F. Spertini,et al.  Ex Vivo Monitoring of Antigen-Specific CD4+ T Cells after Recall Immunization with Tetanus Toxoid , 2007, Clinical and Vaccine Immunology.

[39]  Julie A McMurry,et al.  Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. , 2007, Vaccine.

[40]  William W. Kwok,et al.  Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide , 2006, The Journal of experimental medicine.

[41]  D. Drucker,et al.  Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo. , 2003, Diabetes.

[42]  S. Kaveri,et al.  Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. , 2003, Blood.

[43]  A. D. De Groot,et al.  Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. , 1998, Vaccine.

[44]  R. Kaufman,et al.  Differential Interaction of Coagulation Factor VIII and Factor V with Protein Chaperones Calnexin and Calreticulin* , 1998, The Journal of Biological Chemistry.

[45]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[46]  W. Kane,et al.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Scott,et al.  Effects of methoxypoly (Ethylene glycol) mediated immunocamouflage on leukocyte surface marker detection, cell conjugation, activation and alloproliferation. , 2016, Biomaterials.

[48]  D. Scott,et al.  Tregitope update: mechanism of action parallels IVIg. , 2013, Autoimmunity reviews.

[49]  A. D. De Groot,et al.  An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. , 2011, Immunome research.

[50]  Ray H. Baughman,et al.  Supporting Online Material , 2003 .